Prosecution Insights
Prosecution Insights
10 pending office actions • 9 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (60%) |
| §112 only | 1 (10%) |
| No statute on record | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LUONG, PETER | 1 | 69.0% | +26.9% |
| CHICKS, ASHLI ARIANA | 1 | 64.1% | +44.9% |
| EVANS, TRISTAN ISAAC | 1 | 34.0% | +54.4% |
| AEDER, SEAN E | 1 | 56.9% | +19.6% |
| WANG, RUIXUE | 1 | 57.6% | +23.2% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.6% | +17.0% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 59.3% | +73.3% |
| HAVLIN, ROBERT H | 1 | 52.3% | +27.2% |
| MOORE, SUSANNA | 1 | 68.1% | +31.8% |
| ABRAHAM, AMJAD A | 1 | 30.9% | +37.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17372080 | ORAL ADMINISTRATION OF MELANIN FOR PROTECTION AGAINST RADIATION | ABRAHAM, AMJAD A | 134d overdue |
| 17996302 | INHIBITION OF BAX-MEDIATED CELL DEATH BY ELTROMBOPAG | HAVLIN, ROBERT H | 128d overdue |
| 18041262 | N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF | VISHNYAKOVA, ELENA VLADIMIROVNA | 35d overdue |
| 18282671 | CLINICAL DECISION SUPPORT SYSTEMS EMPLOYING REVERSE PHENOTYPING | EVANS, TRISTAN ISAAC | 1d overdue |
| 18247152 | METHODS OF TREATING VIRAL INFECTIONS WITH PiRNAS OR EXTRACELLULAR VESSICLES RELEASED FROM NEURAL STEM CELLS OR NEURAL PROGENITOR CELLS | POLIAKOVA-GEORGAN, EKATERINA | 14d |
| 18256556 | High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody | AEDER, SEAN E | 21d |
| 18294459 | METHOD OF TREATING AND/OR PREVENTING TYPE 1 DIABETES WITH CEPHARANTHINE | CHICKS, ASHLI ARIANA | 26d |
| 18250685 | REPORTER MYCOBACTERIOPHAGE, ASSAYS AND METHODS COMPRISING THE REPORTER MYCOBACTERIOPHAGE | WANG, RUIXUE | 26d |
| Art Unit | Apps |
|---|---|
| 1626 | 2 |
| 3797 | 1 |
| 3683 | 1 |
| 1642 | 1 |
| 1672 | 1 |
| 1637 | 1 |
| 1691 | 1 |
| 1624 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18658055 | LOW INTENSITY FOCUSED ULTRASOUND FOR TREATING CANCER AND METASTASIS | LUONG, PETER | 3797 | §103 | Non-Final OA | 27d | Pending | May 08, 2024 |
| 18294459 | METHOD OF TREATING AND/OR PREVENTING TYPE 1 DIABETES WITH CEPHARANTHINE | CHICKS, ASHLI ARIANA | 1626 | §103 | Non-Final OA | 26d | Pending | Feb 01, 2024 |
| 18282671 | CLINICAL DECISION SUPPORT SYSTEMS EMPLOYING REVERSE PHENOTYPING | EVANS, TRISTAN ISAAC | 3683 | §103 | Non-Final OA | 1d overdue | Pending | Sep 18, 2023 |
| 18256556 | High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody | AEDER, SEAN E | 1642 | Other | Non-Final OA | 21d | Pending | Jun 08, 2023 |
| 18250685 | REPORTER MYCOBACTERIOPHAGE, ASSAYS AND METHODS COMPRISING THE REPORTER MYCOBACTERIOPHAGE | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 26d | Pending | Apr 26, 2023 |
| 18247152 | METHODS OF TREATING VIRAL INFECTIONS WITH PiRNAS OR EXTRACELLULAR VESSICLES RELEASED FROM NEURAL STEM CELLS OR NEURAL PROGENITOR CELLS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §112 | Non-Final OA | 14d | Pending | Mar 29, 2023 |
| 18041262 | N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103 | Non-Final OA | 35d overdue | Pending | Feb 10, 2023 |
| 17996302 | INHIBITION OF BAX-MEDIATED CELL DEATH BY ELTROMBOPAG | HAVLIN, ROBERT H | 1626 | §103 | Final Rejection | 128d overdue | Pending | Oct 14, 2022 |
| 17855772 | COMPOSITIONS AND METHODS FOR PROVIDING CARDIOPROTECTIVE EFFECTS | MOORE, SUSANNA | 1624 | Other | Final Rejection | 28d | Pending | Jun 30, 2022 |
| 17372080 | ORAL ADMINISTRATION OF MELANIN FOR PROTECTION AGAINST RADIATION | ABRAHAM, AMJAD A | 1663 | Other | Final Rejection | 134d overdue | Pending | Jul 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial